Using your phone's internet browser
go to:  qna.rediff.com
Click and drag this link to
the Home icon in your browser.
Q.

Ranbaxy to delist---news. How far will it be beneficial to the Indian shareholders? Your views?

Asked by Good Citizen, 30 Mar '10 10:38 am
  Invite a friend  |  
  Save  |  
 Earn 10 points for answering
Answer this question  Earn 10 points for answering    
4000 characters remaining  
  
    
Keep me signed inNew User? Sign up

Answers (2)

 
1.

It would be of benefit to the shareholders of the company but the value addition expected over the long term will be missed out due to this as it would have picked up soon after the healthcare bill in US. It would be comparatively more beneficial for Daiichi Sankyo the majority stakeholder which would have the complete control by merging Ranbaxy into itself!!
Answered by dharamender nebhnani, 30 Mar '10 08:56 pm

 
  
Report abuse
Useful
 (2)
Not Useful
 (0)
Your vote on this answer has already been received
2.

The share holders may get one time better price because once the wind of delisting starts blowing,the price of the share will move up n the holders may get a better bargain.
Answered by Damodar Biswal, 30 Mar '10 04:34 pm

 
  
Report abuse
Useful
 (1)
Not Useful
 (0)
Your vote on this answer has already been received

Ask a Question

Get answers from the community

600 characters remaining